EYPT
NASDAQ · Pharmaceuticals
Eyepoint Inc
$3.85
-0.14 (-3.51%)
Open$3.95
Previous Close$3.99
Day High$4.06
Day Low$3.77
52W High$19.11
52W Low$3.42
Volume—
Avg Volume3.52M
Market Cap343.99M
P/E Ratio—
EPS$-3.74
SectorPharmaceuticals
Analyst Ratings
Buy
19 analysts
Price Target
+139.2% upside
Current
$3.85
$3.85
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 34.83M | 38.20M | 211.34M |
| Net Income | -257,518,177 | -254,213,402 | 52.60M |
| Profit Margin | -739.4% | -702.5% | 24.9% |
| EBITDA | -267,691,393 | -278,936,956 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | -8.8% | -8.8% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |